These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 1311588
1. Reduced topoisomerase II and elevated alpha class glutathione S-transferase expression in a multidrug resistant CHO cell line highly cross-resistant to mitomycin C. Hoban PR, Robson CN, Davies SM, Hall AG, Cattan AR, Hickson ID, Harris AL. Biochem Pharmacol; 1992 Feb 18; 43(4):685-93. PubMed ID: 1311588 [Abstract] [Full Text] [Related]
2. Dominant expression of multiple drug resistance after in vitro X-irradiation exposure in intraspecific Chinese hamster ovary hybrid cells. McClean S, Hosking LK, Hill BT. J Natl Cancer Inst; 1993 Jan 06; 85(1):48-53. PubMed ID: 8093217 [Abstract] [Full Text] [Related]
3. Reversal of multidrug resistance by verapamil and modulation by alpha 1-acid glycoprotein in wild-type and multidrug-resistant Chinese hamster ovary cell lines. Chatterjee M, Robson CN, Harris AL. Cancer Res; 1990 May 01; 50(9):2818-22. PubMed ID: 1970277 [Abstract] [Full Text] [Related]
4. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells. Kim WJ, Kakehi Y, Yoshida O. Int J Urol; 1997 Nov 01; 4(6):583-90. PubMed ID: 9477189 [Abstract] [Full Text] [Related]
5. Decreased NADPH:cytochrome P-450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions. Hoban PR, Walton MI, Robson CN, Godden J, Stratford IJ, Workman P, Harris AL, Hickson ID. Cancer Res; 1990 Aug 01; 50(15):4692-7. PubMed ID: 2114946 [Abstract] [Full Text] [Related]
6. Characterization of a Chinese hamster ovary cell line with acquired resistance to the bisdioxopiperazine dexrazoxane (ICRF-187) catalytic inhibitor of topoisomerase II. Hasinoff BB, Kuschak TI, Creighton AM, Fattman CL, Allan WP, Thampatty P, Yalowich JC. Biochem Pharmacol; 1997 Jun 15; 53(12):1843-53. PubMed ID: 9256159 [Abstract] [Full Text] [Related]
7. Isolation and partial characterisation of a mammalian cell mutant hypersensitive to topoisomerase II inhibitors and X-rays. Davies SM, Davies SL, Hall AG, Hickson ID. Mutat Res; 1990 Mar 15; 235(2):111-8. PubMed ID: 2155384 [Abstract] [Full Text] [Related]
8. Multifactorial resistance to antineoplastic agents in drug-resistant P388 murine leukemia, Chinese hamster ovary, and human HeLa cells, with emphasis on the role of DNA topoisomerase II. Deffie AM, McPherson JP, Gupta RS, Hedley DW, Goldenberg GJ. Biochem Cell Biol; 1992 May 15; 70(5):354-64. PubMed ID: 1353968 [Abstract] [Full Text] [Related]
9. Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line. Son YS, Suh JM, Ahn SH, Kim JC, Yi JY, Hur KC, Hong WS, Muller MT, Chung IK. Cancer Chemother Pharmacol; 1998 May 15; 41(5):353-60. PubMed ID: 9523730 [Abstract] [Full Text] [Related]
10. Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase. Lefevre D, Riou JF, Ahomadegbe JC, Zhou DY, Benard J, Riou G. Biochem Pharmacol; 1991 Jun 15; 41(12):1967-79. PubMed ID: 1645555 [Abstract] [Full Text] [Related]
11. Enhancement of Adriamycin cytotoxicity in a multidrug resistant Chinese hamster ovary (CHO) subline, CHO-Adrr, by toremifene and its modulation by alpha 1 acid glycoprotein. Chatterjee M, Harris AL. Eur J Cancer; 1990 Apr 15; 26(4):432-6. PubMed ID: 2141509 [Abstract] [Full Text] [Related]
12. Attenuated topoisomerase II content directly correlates with a low level of drug resistance in a Chinese hamster ovary cell line. Webb CD, Latham MD, Lock RB, Sullivan DM. Cancer Res; 1991 Dec 15; 51(24):6543-9. PubMed ID: 1660341 [Abstract] [Full Text] [Related]
13. Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Fairchild CR, Ivy SP, Kao-Shan CS, Whang-Peng J, Rosen N, Israel MA, Melera PW, Cowan KH, Goldsmith ME. Cancer Res; 1987 Oct 01; 47(19):5141-8. PubMed ID: 2441861 [Abstract] [Full Text] [Related]
14. Chinese hamster ovary cells resistant to okadaic acid express a multidrug resistant phenotype. Tohda H, Yasui A, Yasumoto T, Nakayasu M, Shima H, Nagao M, Sugimura T. Biochem Biophys Res Commun; 1994 Sep 15; 203(2):1210-6. PubMed ID: 7916570 [Abstract] [Full Text] [Related]
15. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line. de Jong S, Zijlstra JG, de Vries EG, Mulder NH. Cancer Res; 1990 Jan 15; 50(2):304-9. PubMed ID: 1967222 [Abstract] [Full Text] [Related]
16. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line. Naito S, Hasegawa S, Yokomizo A, Koga H, Kotoh S, Kuwano M, Kumazawa J. Jpn J Cancer Res; 1995 Nov 15; 86(11):1112-8. PubMed ID: 8567404 [Abstract] [Full Text] [Related]
17. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport. Lee FY, Sciandra J, Siemann DW. Biochem Pharmacol; 1989 Nov 01; 38(21):3697-705. PubMed ID: 2574574 [Abstract] [Full Text] [Related]
18. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines. Sehested M, Wessel I, Jensen LH, Holm B, Oliveri RS, Kenwrick S, Creighton AM, Nitiss JL, Jensen PB. Cancer Res; 1998 Apr 01; 58(7):1460-8. PubMed ID: 9537249 [Abstract] [Full Text] [Related]
19. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi. Fairchild CR, Moscow JA, O'Brien EE, Cowan KH. Mol Pharmacol; 1990 Jun 01; 37(6):801-9. PubMed ID: 1972772 [Abstract] [Full Text] [Related]
20. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells. de Jong S, Kooistra AJ, de Vries EG, Mulder NH, Zijlstra JG. Cancer Res; 1993 Mar 01; 53(5):1064-71. PubMed ID: 8382551 [Abstract] [Full Text] [Related] Page: [Next] [New Search]